Validation of a French adaptation of the International Prostatic Symptom Score;Validation d'une adaptation française de l'échelle internationale de cotation des symptômes prostatiques

Progres en Urologie

Volumn 6, Issue 2, 1996, Pages 240-249

  Gregoire, Jean Pierre ^a   Moisan, Jocelyne ^a   Labrecque, Michel ^a   Cusan, Leonello ^a   Diamond, Pieire ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

General state of health; Prostatic hypertrophy; Quality of life; Questionnaires

Indexed keywords

AGED; ARTICLE; EVALUATION; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PROSTATE HYPERTROPHY; QUESTIONNAIRE;

AGED; AGED, 80 AND OVER; EVALUATION STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0030116774     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Association des urologues du Québec: Guide pratique au sujet du traitement médical de l'hypertrophie bénigne de la prostate (HBP). 1993.
2. BARRY M.J., FOWLER F.J., O'LEARY M.P. et al : The American Urological Association Symptom Index for Benign Prostatic Hyperplasia J. Urol., 1992, 148, 1549-1557
3. CARMINES E.G., ZELLER R.A.: Reliability and validity assesment. Quantitative applications in the social sciences series. Beverly Hills: Sage Publications, 1979.
4. CHWALOW A.J., Cross-cultural validation of existing quality of life scales. Patient education and counselling, 1995, 26, 313-318.
5. COCKETT A.T.K., ASO Y., DENIS L. et al.: Recommendations of the International Consensus Committee concerning: 1. Prostate Symptom Score (I-PSS) and Quality of Life Assessment: 2. Diagnostic work-up of patients presenting with symptoms suggestive of prostatism; 3. Patient evaluation for research studies; 4. BPH treatment. In: Proceedings of the International Consultation on Benign Prostatic Hyperplasia (BPH). Edited by A.T.K. Cockett. Y. Aso. C. Chatelain et al, Paris June 26-27, 1991. Paris, France: SCI, 1992, 279-288.
6. FLEISS J.L.: Statistical methods for rates and proportions. New York:Wiley, 1981.
7. GARRAWAY W.M., RUSSELL E.B.A.W., LEE R J. et al.: Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Brit. J. General. Practice, 1993, 43, 318-321.
8. KLEINBAUM D.G., KUPPER L.L.: Applied regression analysis and other multivariable methods. Boston: Duxbury Press, 1978.
9. KRAMER M.S : Clinical epidemiology and biostatistics. New York. Springer-Verlag, 1988
10. ROEHRBORN C., DI SYLVERIO F., LERICHE A., RUBBEN H., WATANABE H.: Diagnostic work-up of patients presenting symptoms suggestive of prostatism. In. Proceedings of the International Consultation on Benign Prostatic Hyperplasia (BPH). Edited by A.T.K. Cockett, Y. Aso, C. Chatelain et al. Paris June 26-27, 1991. Paris, France: SCI, 1992, 93-135.
11. SAGNIER P.-P., RICHARD F., BOTTO H., TEILLAC P., DREYFUS J.-P, BOYLE P.: Adaptation et validation en langue française du score international des symptômes de l'hypertrophie bénigne de la prostate. Prog. Urol. 1994, 4, 532-540.
12. SEITTER W.R , BARRET-CONNOR E.: Cigarette smoking, obesity and benign prostatic hypertrophy: A prospective population-based study. Am J. Epidemiol., 1992, 135, 500-503.